Reference : Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
Scientific journals : Article
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/155564
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
English
NEUPREZ, Audrey mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine de l'appareil locomoteur >]
Coste, S []
Rompen, Eric mailto [Université de Liège - ULiège > Département de sciences dentaires > Chirurgie bucco-dentaire et parodontologie >]
Crielaard, Jean-Michel mailto [Université de Liège - ULiège > Département des sciences de la motricité > Evaluation et entraînement des aptitudes physiques >]
REGINSTER, Jean-Yves mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine de l'appareil locomoteur >]
2014
Osteoporosis International
25
393-395
Yes (verified by ORBi)
International
0937-941X
1433-2965
[en] Osteonecrosis of the jaw (ONJ) is a clinical condition associated with long-term exposure to inhibitors of bone resorption, mainly bisphosphonates. Denosumab (DMab) is a human monoclonal antibody of the receptor activator of nuclear factor kappa-B ligand. It prevents osteoclast-mediated bone resorption and is widely prescribed for the management of postmenopausal osteoporosis. Whereas ONJ has already been reported in women treated with DMab, we report for the first time the development of ONJ, following tooth extraction, in a male patient treated for idiopathic osteoporosis with DMab. Due to the constant increase in DMab prescription, for the management of osteoporosis, in both genders, physicians should be made aware of this potential risk.
http://hdl.handle.net/2268/155564
10.1007/s00198-013-2437-z

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab.pdfPublisher postprint123.43 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.